- Source type
- Article
- Access type
- Publisher
- Publisher
- Insulet
- Date
- 2026
- Added
- 2026-07-05
Trust profile
VV Source Trust Matrix v1.0
VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.
60
General published source
- Publisher type
- General media
- Bias profile
- Elevated
This source is strongest for consumer context and regulatory status and weaker for safety and trial discovery.
VV Source Fit Score 1.0
Fit by use case
Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.
- Regulatory status
- 54/100
- Weak Support
- Clinical outcomes
- 54/100
- Weak Support
- Mechanism
- 54/100
- Weak Support
- Safety
- 54/100
- Weak Support
- Consumer context
- 67/100
- Context Source
- Trial discovery
- 54/100
- Weak Support
Best used for
- Context
- Public narrative
Weak for
- Clinical claims
- Safety conclusions
- Regulatory status
Used in Viral Vitalism
FDA Flagged a Serious Omnipod Insulin-Delivery Recall
Roles: Background
Related studies
No structured study record is currently attached to this source.
Related sources
FDA: Insulet removes certain Omnipod Pods
Primary Class I recall source for affected Omnipod Pods and insulin under-delivery risk.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 1 connection
Medical Xpress: hospital AI predicts low blood sugar up to 24 hours in advance
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 60
- Publisher
- Medical Xpress
- Access
- Publisher
- Usage
- 0 connections
Newswise: Wistar scientists develop single-dose DNA method
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 60
- Publisher
- Newswise
- Access
- Publisher
- Usage
- 0 connections
Reuters: GLP-1s linked to smell and taste impairment in diabetes patients
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 60
- Publisher
- Reuters
- Access
- Publisher
- Usage
- 1 connection
Trends in Biotechnology: single-dose plasmid DNA for designer incretins
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 60
- Publisher
- Trends in Biotechnology
- Access
- Publisher
- Usage
- 0 connections
Omnipod: Current Podders correction resources
Manufacturer customer-resource page for affected Omnipod Pod lots and replacement guidance.
- Trust score
- 82
- Publisher
- Insulet / Omnipod
- Access
- Publisher
- Usage
- 1 connection
